Abstract
We prospectively analyzed the clinical outcomes of 72 patients (2,3) and we came to similar conclusions. Conceptually, covered stents present the advantage to prevent tumor ingrowth within the stent, and, being more compliant, they could facilitate pyloric motility. However, they dislodge more easily, and distal migration of the stent can lead to serious consequences (4).
This article is protected by copyright. All rights reserved.
from #Esophageal Cancer via a.lsfakia on Inoreader http://ift.tt/2phGDGt
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου